Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer - Top-Institutions - MDSpire

Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer

  • By

  • Haoran Zhu

  • Yuankun Cai

  • ChongWei Ke

  • Huipeng Wang

  • February 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Medical Oncology
    • Radiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Surgical Oncology
    • Radiation Oncology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Surgical Oncology
    • Gastroenterology
    • Radiology

  • #4

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Surgical Oncology
    • Radiology
    • Medical Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Surgical Oncology
    • Medical Oncology
    • Radiology

Original Source(s)

Assessment of Clinical Risk Factors and Survival Outcomes in Postoperative Recurrence or Metastasis of Colorectal Cancer

  • by Haoran Zhu, Yuankun Cai, ChongWei Ke, Huipeng Wang

  • February 24, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant